A significant lung cancer treatment option that costs approximately $88,000 a year will soon be available for as little as $6.60 per script, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS). From 1 January 2021, Australians living with non-small cell lung cancer who have not had prior therapy will benefit from the listing…
I am very sad to hear of the passing of Doug Anthony today. I always felt I was in the presence of a legend when I was with Doug. He was always easy with a warm smile and interest in how you were going. The Nationals are 100 years old this year…
Mobile phone towers on the North Coast will now be able to keep operating if the power goes out due to natural disasters. The Federal Government is funding mobile providers to extend the battery back up at 11 mobile phone towers in our community, to provide a minimum of 12 hours of back-up power. Federal…
Shows and field days cancelled due to COVID-19 are about to get a slice of $34 million Federal Government funding to ensure they can bounce back in 2021. Federal Member for Page Kevin Hogan said the first payments under the Supporting Agricultural Shows and Field Days program will roll out before Christmas. “Two…
Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded access to a breakthrough medicine through the Pharmaceutical Benefits Scheme (PBS). From 1 December, access to Venclexta® (venetoclax) will be extended in combination with obinutuzumab for the first-line treatment of patients with chronic lymphocytic leukaemia who have…